GlassScriptPhysician profile
Hector L Fernandez
NPI 1720022635
$4,508.92
in general payments reported to CMS, 2019-2025
19 companies · $93.51 in 2025
The $93.51 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $284 · 2020: $3,482 · 2021: $49.81 · 2022: $298 · 2023: $151 · 2024: $151 · 2025: $93.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $396.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $395.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,382.68 | 2020 | |
| Abbvie INC. | $371.93 | 2019-2025 | |
| Astellas Pharma US INC | $148.05 | 2022-2024 | Veozah |
| Allergan, INC. | $89.67 | 2019-2020 | |
| Hologic Sales and Service, LLC | $86.95 | 2019-2025 | Aptima, Thinprep 2000 Processor |
| Mayne Pharma Commercial LLC | $56.96 | 2022-2023 | |
| Evofem Biosciences, INC. | $54.83 | 2024-2025 | Solosec, Phexx, Phexxi |
| Mission Pharmacal Company | $54.03 | 2019 | |
| Glaxosmithkline, LLC. | $43.99 | 2022 | |
| Duchesnay USA Incorporated | $35.56 | 2019 | |
| Shield Therapeutics INC | $35.09 | 2022-2023 | Accrufer |
| Coloplast Corp | $30.18 | 2019-2021 | |
| Smith+Nephew, INC. | $24.60 | 2024 | Pico 14, Renasys Touch |
| Exeltis, USA INC. | $22.07 | 2025 | Slynd |
| Organon LLC | $19.77 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $17.97 | 2020 | |
| Ethicon US, LLC | $17.52 | 2019 | |
| Coopersurgical, INC. | $17.07 | 2024 | Paragard T 380a |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hector Fernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.